BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 18164908)

  • 1. Vancomycin-resistant enterococci (VRE): transmission and control.
    Tacconelli E; Cataldo MA
    Int J Antimicrob Agents; 2008 Feb; 31(2):99-106. PubMed ID: 18164908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of vancomycin-resistant enterococci via health care worker hands.
    Duckro AN; Blom DW; Lyle EA; Weinstein RA; Hayden MK
    Arch Intern Med; 2005 Feb; 165(3):302-7. PubMed ID: 15710793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of nosocomial transmission of vancomycin-resistant enterococci from isolated patients.
    Cheng AC; Harrington G; Russo P; Liolios L; Spelman D
    Intern Med J; 2004 Aug; 34(8):510-2. PubMed ID: 15317552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci.
    Drees M; Snydman DR; Schmid CH; Barefoot L; Hansjosten K; Vue PM; Cronin M; Nasraway SA; Golan Y
    Clin Infect Dis; 2008 Mar; 46(5):678-85. PubMed ID: 18230044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units.
    Perencevich EN; Fisman DN; Lipsitch M; Harris AD; Morris JG; Smith DL
    Clin Infect Dis; 2004 Apr; 38(8):1108-15. PubMed ID: 15095215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci.
    Hayden MK
    Clin Infect Dis; 2000 Oct; 31(4):1058-65. PubMed ID: 11049790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of persistent gastrointestinal colonization on the transmission dynamics of vancomycin-resistant enterococci.
    D'Agata EM; Horn MA; Webb GF
    J Infect Dis; 2002 Mar; 185(6):766-73. PubMed ID: 11920294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin-resistant enterococci (VRE) and the role of the healthcare worker.
    Ott M; Wirick H
    Can Oper Room Nurs J; 2008 Mar; 26(1):21-4, 26-9, 32. PubMed ID: 18444472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance and endemic vancomycin-resistant enterococci: some success in control is possible.
    Morris-Downes M; Smyth EG; Moore J; Thomas T; Fitzpatrick F; Walsh J; Caffrey V; Morris A; Foley S; Humphreys H
    J Hosp Infect; 2010 Jul; 75(3):228-33. PubMed ID: 20363048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antecedent intravenous antimicrobial exposure and isolation of vancomycin-resistant enterococci.
    Chavers LS; Moser SA; Funkhouser E; Benjamin WH; Chavers P; Stamm AM; Waites KB
    Microb Drug Resist; 2003; 9 Suppl 1():S69-77. PubMed ID: 14633370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment.
    Hayden MK; Blom DW; Lyle EA; Moore CG; Weinstein RA
    Infect Control Hosp Epidemiol; 2008 Feb; 29(2):149-54. PubMed ID: 18179370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures.
    Hayden MK; Bonten MJ; Blom DW; Lyle EA; van de Vijver DA; Weinstein RA
    Clin Infect Dis; 2006 Jun; 42(11):1552-60. PubMed ID: 16652312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-factors and predictors of mortality in patients colonised with vancomycin-resistant enterococci.
    Sakka V; Tsiodras S; Galani L; Antoniadou A; Souli M; Galani I; Pantelaki M; Siafakas N; Zerva L; Giamarellou H
    Clin Microbiol Infect; 2008 Jan; 14(1):14-21. PubMed ID: 18005178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of vancomycin-resistant enterococci: one size fits all?
    Armeanu E; Bonten MJ
    Clin Infect Dis; 2005 Jul; 41(2):210-6. PubMed ID: 15983917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
    Martínez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
    Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of vancomycin-resistant enterococcus colonization at Gaziantep Children's Hospital, Turkey].
    Yiş R; Aslan S; Cıtak C; Değirmenci S
    Mikrobiyol Bul; 2011 Oct; 45(4):646-54. PubMed ID: 22090295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital.
    Lucet JC; Armand-Lefevre L; Laurichesse JJ; Macrez A; Papy E; Ruimy R; Deblangy C; Lozach A; Lolom I; Jarlier V; Andremont A; Leport C
    J Hosp Infect; 2007 Sep; 67(1):42-8. PubMed ID: 17719129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
    Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
    Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.
    Calfee DP; Giannetta ET; Durbin LJ; Germanson TP; Farr BM
    Clin Infect Dis; 2003 Aug; 37(3):326-32. PubMed ID: 12884155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant enterococci: consequences for therapy and infection control.
    Mascini EM; Bonten MJ
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():43-56. PubMed ID: 15953021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.